Results 191 to 200 of about 74,287 (302)
Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management
Thyroid cancer risk is influenced by both genetic and modifiable factors, including mutations, radiation exposure, lifestyle, and pre‐existing benign conditions. Diagnosis involves physical exams, ultrasound, scintigraphy, laboratory tests, and fine‐needle aspiration biopsy (FNAB).
Yu‐Dong Li +3 more
wiley +1 more source
Incidental finding of bone tracer accumulation in gastrointestinal stromal tumor: Two case reports. [PDF]
Chan GKW, Chow TK, Hui YH, Ho WY.
europepmc +1 more source
Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study
ABSTRACT Objectives Neuroblastoma is the most common extracranial solid tumor in infants, with a possibility of spontaneous regression even in disseminated disease. Despite an overall good prognosis, relapse can worsen the outcome for some patients. A long‐term analysis is crucial to identify subgroups of patients with poorer prognosis, assessing the ...
Julie Savagner +21 more
wiley +1 more source
A Review of Thyroid Rests: From Embryology to Clinical Management. [PDF]
Aldawas G, Ragab S.
europepmc +1 more source
Ileal Biofilms Confirm SIBO–IBS Hypothesis: Comment on PMID 38798120
Neurogastroenterology &Motility, EarlyView.
Maximilian Baumgartner, Christoph Gasche
wiley +1 more source
Abstract Background In neuroblastoma (NB), urinary catecholamine excretion and 123ImIBG avidity—depending on tumor enzymatic activity and norepinephrine transporter expression, respectively—are diagnostic standards. The prognostic impact of atypical NB, without urinary catecholamine excretion and/or 123ImIBG avidity, remains to be determined. We sought
Anna Borovkov +27 more
wiley +1 more source
Quantitative whole-body dynamic planar scintigraphy in mice with <sup>99m</sup>Tc and <sup>161</sup>Tb. [PDF]
Wright JD +6 more
europepmc +1 more source
A CASE OF PARAGANGLIOMA DIAGNOSED BY <sup>131</sup>I-METAIODOBENZYL GUANIDINE (MIBG) SCINTIGRAPHY
Susumu Kubo +9 more
openalex +2 more sources
Abstract Background Erectile dysfunction (ED) affects up to 50% of men over 40. While phosphodiesterase‐5 inhibitors (PDE5i) are the first line of medical treatment, they are not always effective. Alprostadil, available in injectable, topical, and intraurethral forms, offers an alternative treatment modality.
Iason Papadopoulos +8 more
wiley +1 more source

